← Eichor
Study identifier: NCT00710177 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn

Condition: Persistent Pulmonary Hypertension of the Newborn  ·  Sponsor: Medical College of Wisconsin

PhaseN/A
Planned participants200
Who can joinAll sexes, N/A to 12 Months
Healthy volunteersYes

About this study

The purpose of this study is to determine if normally occurring variations in a specific gene called PTGS-1 are associated with an increased risk of narrowing of the ductus arteriosus from exposure to over-the-counter pain medicines (NSAIDs).

This description comes directly from the study's public registry record.

Talk to the study team

G. Ganesh Konduri, MD  ·  414-266-6820  ·  gkonduri@mcw.edu

Kathleen M Meskin, BSN  ·  414-337-7171  ·  kmeskin@mcw.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's WisconsinMilwaukee, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00710177